Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.
about
Neuropathology and animal models of autism: genetic and environmental factorsExploring the Validity of Valproic Acid Animal Model of AutismThe Intense World Theory – A Unifying Theory of the Neurobiology of AutismEnteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disordersDoes Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition.Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Mouse models of autism: testing hypotheses about molecular mechanisms.Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspringEarly cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanolThe intense world syndrome--an alternative hypothesis for autismDecreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid.A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic childrenSuppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors.Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autismLipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of OffspringTherapeutic potency of bee pollen against biochemical autistic features induced through acute and sub-acute neurotoxicity of orally administered propionic acid.Etiology of autistic features: the persisting neurotoxic effects of propionic acidTriggers for autism: genetic and environmental factors.Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorderAutism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Increased IgG4 levels in children with autism disorder.Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndromePrenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.Thalidomide and its analogues: A review of the potential for immunomodulation of fibrosis diseases and opthalmopathy.Serotonin neuron abnormalities in the BTBR mouse model of autism.Investigating the effects of environmental factors on autism spectrum disorder in the USA using remotely sensed data.Evidence for Brainstem Contributions to Autism Spectrum DisordersEfficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neuronsPotentiation of Glutamatergic Synaptic Transmission Onto Dorsal Raphe Serotonergic Neurons in the Valproic Acid Model of Autism
P2860
Q21284779-47F9C1D5-50D3-4B7D-B03D-9E7D53D08940Q26771764-BF203808-0100-4DAC-8023-F387B7DBC3A3Q27500386-C83FDE21-D456-4914-8308-2C16E8EEA916Q28542649-11CB1A71-ACBC-4929-AB59-93270E76CF9BQ30372826-FC449593-D0BD-4D41-8B4C-057DD2C86627Q30443028-7862E89E-488A-47F2-9A88-4CBB24F5F9AFQ30465721-637133A6-5BAB-4BFE-B7D2-AC45B81F6666Q34360515-3093DA40-5C3A-4562-A068-1298289DD041Q34582417-5234C4E4-81F3-422C-A041-B1D756D56655Q34871941-4999FABA-BB42-4074-AC5C-4FE7C7DC9898Q35017799-C83256BF-2F7C-4F78-AE49-C5F75B604764Q35123969-A29C2382-415C-491C-9A9D-3EB08AC7FE39Q35650220-F183062E-8911-4FD0-A077-668BA950AFE5Q35686555-B125F903-AED7-42CC-8BE6-1E79E36597C7Q35719523-3B48DC3E-581D-4665-8E01-F07D2D762D0BQ35997523-115AB3B0-045E-443A-91C6-242EBB0A66EEQ36181687-DBF17A29-49F7-45D6-9721-2C644D148F01Q36748307-9C832467-9AF0-4C12-A9CC-3E58AFF410AEQ36921232-FDCD7BD7-67D2-4FFE-92C8-F28B5D333542Q36949345-E5A96804-C504-438F-9E27-12BBAC417F22Q37068738-884C9B0A-B84D-4544-B5A8-BC9522102C00Q37227405-CD309085-3CCB-4378-A7CD-879B52CC8EDCQ37438521-C9C3D995-4851-4B36-98E5-2427340F7154Q37509237-D17C7B8C-68B5-48C8-BD2C-AA25A8986DCBQ47096268-42EA3823-5CC1-43E8-9D42-A82A2775A9C6Q47137996-6FB6AA11-9941-4513-83B5-1DE096FFC151Q47201485-2DA6AFFA-0AF8-4034-AE17-8E0571C11CEBQ58583908-C0FC151A-519B-461C-B404-CA6CE754AA7FQ59101361-74AA134F-294C-4A62-98AE-30EA72AEF1ACQ59128049-34CA4C2D-0234-4591-9C03-78010A9E800C
P2860
Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Increased monoamine concentrat ...... tive animal models for autism.
@en
Increased monoamine concentrat ...... tive animal models for autism.
@nl
type
label
Increased monoamine concentrat ...... tive animal models for autism.
@en
Increased monoamine concentrat ...... tive animal models for autism.
@nl
prefLabel
Increased monoamine concentrat ...... tive animal models for autism.
@en
Increased monoamine concentrat ...... tive animal models for autism.
@nl
P2093
P2860
P1433
P1476
Increased monoamine concentrat ...... tive animal models for autism.
@en
P2093
Kaoru Miyazaki
Mami Tazoe
Masaaki Narita
Michiko Kato
Naoko Narita
Nobuo Okado
P2860
P304
P356
10.1203/00006450-200210000-00018
P407
P577
2002-10-01T00:00:00Z
P5875
P6179
1049780177